{
    "clinical_study": {
        "@rank": "70304", 
        "acronym": "MID-Frail", 
        "arm_group": [
            {
                "arm_group_label": "Usual Care Group", 
                "arm_group_type": "No Intervention", 
                "description": "Subjects undergo usual standard of care"
            }, 
            {
                "arm_group_label": "Intervention Group", 
                "arm_group_type": "Experimental", 
                "description": "Intervention with exercise, dietary and educational programs"
            }
        ], 
        "brief_summary": {
            "textblock": "The MID-Frail STUDY project focuses on the use of interventions designed to improve\n      functional status and enhance quality of life (rather than traditional treatments such as\n      glucose- and blood pressure- lowering) by acting on the mechanisms involved in producing\n      frailty and its progression to adverse outcomes."
        }, 
        "brief_title": "Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 Diabetes", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Participant is willing and able to give written informed consent for participation in\n             the study.\n\n          -  Subjects aged 70 years or older, with a diagnosis of type 2 diabetes mellitus for at\n             least 2 years.\n\n          -  Require to fulfill Fried \u0301s criteria for frail or pre-frail individuals.\n\n        Exclusion criteria:\n\n          -  Barthel score lower than 60 points.\n\n          -  Inability to carry out SPPB test (total score=0).\n\n          -  Mini Mental State Examination score less than 20 points.\n\n          -  Subjects unwilling or unable to consent or unable to participate safely in\n             intervention program.\n\n          -  Previous history of myocardial infarction within 6 months, unstable angina or\n             congestive heart failure in III-IV NYHA stage.\n\n          -  Clinically instable patients in the clinical judgment of the investigator.\n\n          -  Terminal illness (life expectancy < 6 months).\n\n          -  Any other condition that, in the clinical judgment of the investigator, means that it\n             would not in the patient's best interests to enter the study.\n\n          -  Current participation in clinical trial or any other investigational study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "70 Years"
        }, 
        "enrollment": {
            "#text": "1718", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01654341", 
            "org_study_id": "MID-Frail", 
            "secondary_id": "278803-2"
        }, 
        "intervention": {
            "arm_group_label": "Intervention Group", 
            "intervention_name": "Exercise, dietary and educational program", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 30, 2012", 
        "location": {
            "contact": {
                "email": "lrodriguez.hugf@salud.madrid.org", 
                "last_name": "Leocadio Rodr\u00edguez Ma\u00f1as, MD", 
                "phone": "00 34 916839360", 
                "phone_ext": "6512"
            }, 
            "facility": {
                "address": {
                    "city": "Madrid", 
                    "country": "Spain", 
                    "state": "Getafe", 
                    "zip": "28905"
                }, 
                "name": "Hospital Universitario de Getafe"
            }, 
            "investigator": {
                "last_name": "Leocadio Rodr\u00edguez Ma\u00f1as, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "A RANDOMIZED CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF A MULTI-MODAL INTERVENTION IN FRAIL AND PREFRAIL OLDER PEOPLE WITH TYPE 2 DIABETES ON FRAILTY AND QUALITY OF LIFE: THE MID-Frail STUDY", 
        "overall_contact": {
            "email": "lrodriguez.hugf@salud.madrid.org", 
            "last_name": "Leocadio Rodr\u00edguez Ma\u00f1as, MD", 
            "phone": "00 34 916839360", 
            "phone_ext": "6412"
        }, 
        "overall_contact_backup": {
            "email": "briquelme.hugf@salud.madrid.org", 
            "last_name": "Bel\u00e9n Riquelme"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The Short Physical Performance Battery (SPPB) is a simple test to measure lower extremity function using tasks that mimic daily activities. The SPPB examines 3 areas of lower extremity function; static balance, gait speed, and getting in and out of a chair. These areas represent essential tasks important for independent living and are thus an important outcome measure for patients with cardiovascular and pulmonary disease.", 
            "measure": "Changes in summary ordinal score on the Short Physical Performance Battery test", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01654341"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Lawton IADL scale", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Barthel ADL index", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Euro-QoL index", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Economic costs/healthcare expenditure due to diabetes and its impact on disability and quality of life, using an economic model embracing the direct health-related costs (in-patient, out-patient, pharmaceutical, etc), formal care costs (home care, respite care, day centers, etc) and the informal care costs (carer).", 
                "measure": "Economic costs/healthcare expenditure due to diabetes and its impact on disability and quality of life,", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Episodes of symptomatic hypoglycaemia (i.e., a recorded blood sugar less than 4 mmol/L, or symptoms or signs attributed to low blood sugar and responding to appropriate treatment)", 
                "measure": "Symptomatic hypoglycaemia", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Episodes of hospital admission (i.e., any admission involving an overnight stay)", 
                "measure": "Hospital admissions", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Episodes of permanent institutionalization (i.e., permanent move to any care setting other than the patient's own home, where paid staff are available to provide care if needed at any time during the day or night).", 
                "measure": "Episodes of permanent institutionalization", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Burden of the carer, as assessed by the modified Caregiver Strain Index", 
                "measure": "Caregiver Strain Index", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Mortality", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }
        ], 
        "source": "Institute of Diabetes for Older People", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Servicio Madrileno de Salud", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Bedfordshire", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Cardiff University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Igen Biotech SL", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Chu Hopitaux de Bordeaux", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Hexabio Sarl", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Seconda Universita Degli Studi Di Napoli", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Centre Hospitalier Universitaire de Toulouse", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Universitaet Ulm", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Universiteit Gent", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Castilla-La Mancha", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Univerzita Karlova v Praze", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Consorcio de Apoyo a la Investigacion Biomedica en Red", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Niche Science & Technology Ltd", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Catholic University of the Sacred Heart", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Vrije Universiteit Brussel", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Institute of Diabetes for Older People", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }
}